VEDANTA

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Study Details | VE303 for Prevention of Recurrent Clostridioides Difficile Infection | ClinicalTrials.gov

​

​

ASTRAZENECA

A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides difficile Infection in Individuals 18 Years of Age and Above

​Study Details | NCT07285213 | Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody | ClinicalTrials.gov

​

​